Knockdown and small-molecule facilitated degradation of ANO1 impairs HNSCC and ESCC cell proliferation and have been shown to correlate with the inhibition of mitogen-activated kinase (MAPK) and protein kinase B (AKT) signaling [33, 34, 39]. The gene discussed is AKT1; the disease is head and neck squamous cell carcinoma.